The functions and regulation of the PTEN tumour suppressor
The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Abstract
The importance of the physiological function of phosphatase and tensin homologue (PTEN) is illustrated by its frequent disruption in cancer. By suppressing the phosphoinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway through its lipid phosphatase activity, PTEN governs a plethora of cellular processes including survival, proliferation, energy metabolism and cellular architecture. Consequently, mechanisms regulating PTEN expression and function, including transcriptional regulation, post-transcriptional regulation by non-coding RNAs, post-translational modifications and protein-protein interactions, are all altered in cancer. The repertoire of PTEN functions has recently been expanded to include phosphatase-independent activities and crucial functions within the nucleus. Our increasing knowledge of PTEN and pathologies in which its function is altered will undoubtedly inform the rational design of novel therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the majority of prostate cancer patients at presentation have lost one allele of PTEN while maintaining intact TP53; whereas TP53 mutations and the complete loss of PTEN are both associated with advanced stage prostate cancer 153,154”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [154]
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Salmena, L., Poliseno, L., Tay, Y., Kats, L., & Pandolfi, P. P. (2011) · Cell · doi:10.1016/j.cell.2011.07.014 · Cited by 7,262
Self-citationAKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
Cited by
Items 201–300 of 1,010
Dual function of the PI3K-Akt-mTORC1 axis in myelination of the peripheral nervous system
Figlia, G., Norrmén, C., Pereira, J. A., Gerber, D., & Suter, U. (2017) · eLife · doi:10.7554/elife.29241 · Cited by 114
The regulatory roles of phosphatases in cancer
Stebbing, J., Lit, L. C., Zhang, H., Darrington, R. S., Melaiu, O., Rudraraju, B., & Giamas, G. (2013) · Oncogene · doi:10.1038/onc.2013.80 · Cited by 125
Zanzottera, E. C., Messinger, J. D., Ach, T., Smith, R. T., & Curcio, C. A. (2015) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.15-16432 · Cited by 110
Bhatt, K., Wei, Q., Pabla, N., Dong, G., Mi, Q.-S., Liang, M., Mei, C., & Dong, Z. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014050463 · Cited by 114
mTOR and metabolic pathways in T cell quiescence and functional activation
Yang, K., & Chi, H. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.12.004 · Cited by 130
Challenges and Opportunities in the Development of Protein Phosphatase-Directed Therapeutics
Munter, S. D., Köhn, M., & Bollen, M. (2012) · ACS Chemical Biology · doi:10.1021/cb300597g · Cited by 120
The many substrates and functions of NEDD4-1
Huang, X., Chen, J., Cao, W., Yang, L., Chen, Q., He, J., Yi, Q., Huang, H., Zhang, E., & Cai, Z. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2142-8 · Cited by 119
Li, G., Panday, S. K., & Alexov, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020606 · Cited by 114
Mouse models of prostate cancer: picking the best model for the question
Grabowska, M. M., DeGraff, D. J., Yu, X., Jin, R. J., Chen, Z., Borowsky, A. D., & Matusik, R. J. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9487-8 · Cited by 132
Protein tyrosine phosphatase variants in human hereditary disorders and disease susceptibilities
Hendriks, W. J. A. J., & Pulido, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.022 · Cited by 131
MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential
Rawat, M., Kadian, K., Gupta, Y. A., Kumar, A., Chain, P. S. G., Kovbasnjuk, O. N., Kumar, S., & Parasher, G. (2019) · Genes · doi:10.3390/genes10100752 · Cited by 129
PTEN mediates Notch-dependent stalk cell arrest in angiogenesis
Serra, H., Chivite, Í., Angulo‐Urarte, A., Soler, A., Sutherland, J. D., Arruabarrena-Aristorena, A., Ragab, A., Lim, R., Malumbres, M., Fruttiger, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms8935 · Cited by 120
Self-citationRosewick, N., Durkin, K., Artesi, M., Marçais, A., Hahaut, V., Griebel, P. J., Arsic, N., Avettand-Fènoël, V., Burny, A., Charlier, C., et al. (2017) · Nature Communications · doi:10.1038/ncomms15264 · Cited by 128
De Lorenzo, S. B., Patel, A. G., Hurley, R. M., & Kaufmann, S. H. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00228 · Cited by 111
Martínez-Cisuelo, V., Gómez, J., García-Junceda, I., Naudí, A., Cabré, R., Mota‐Martorell, N., Lopez‐Torres, M., González-Sánchez, M., Pamplona, R., & Barja, G. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.08.002 · Cited by 114
Functionally distinct groups of inherited PTEN mutations in autism and tumour syndromes
Spinelli, L., Black, F. M., Berg, J. N., Eickholt, B. J., & Leslie, N. R. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102803 · Cited by 109
Yan, S., Zhang, H., Zheng, F., Sheng, N., Guo, X., & Dai, J. (2015) · Scientific Reports · doi:10.1038/srep11029 · Cited by 110
Genetic control of postnatal human brain growth
van Dyck, L. I., & Morrow, E. M. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000405 · Cited by 118
MicroRNAs in gynecological cancers: Small molecules with big implications
Srivastava, S. K., Ahmad, A., Zubair, H., Miree, O., Singh, S., Rocconi, R. P., Scalici, J. M., & Singh, A. P. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.011 · Cited by 114
The apoptotic perspective of autism
Wei, H., Alberts, I. L., & Li, X. (2014) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2014.04.004 · Cited by 123
Akl, H., & Bultynck, G. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.12.001 · Cited by 112
Influence of mTOR in energy and metabolic homeostasis
Haissaguerre, M., Saucisse, N., & Cota, D. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.07.015 · Cited by 126
Adaptive Mitochondrial Reprogramming and Resistance to PI3K Therapy
Ghosh, J. C., Siegelin, M. D., Vaira, V., Faversani, A., Tavecchio, M., Chae, Y. C., Lisanti, S., Rampini, P., Giroda, M., Caino, M. C., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju502 · Cited by 108
Molecular functions of NEDD4 E3 ubiquitin ligases in cancer
Zou, X., Levy‐Cohen, G., & Blank, M. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.06.005 · Cited by 110
Targeting tumor suppressor genes for cancer therapy
Liu, Y., Hu, X., Han, C., Wang, L., Zhang, X., He, X., & Lu, X. (2015) · BioEssays · doi:10.1002/bies.201500093 · Cited by 107
Fighting Fire with Fire: Endogenous Retrovirus Envelopes as Restriction Factors
Malfavon-Borja, R., & Feschotte, C. (2015) · Journal of Virology · doi:10.1128/jvi.03653-14 · Cited by 115
A map of directional genetic interactions in a metazoan cell
Fischer, B., Sandmann, T., Horn, T., Billmann, M., Chaudhary, V., Huber, W., & Boutros, M. (2015) · eLife · doi:10.7554/elife.05464 · Cited by 106
Burkhardt, B., & Hermiston, M. L. (2019) · British Journal of Haematology · doi:10.1111/bjh.15793 · Cited by 105
Inhibition of Rb Phosphorylation Leads to mTORC2-Mediated Activation of Akt
Zhang, J., Xu, K. L., Liu, P., Geng, Y., Wang, B., Gan, W., Guo, J., Wu, F., Chin, Y. R., Berrios, C. J., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.04.023 · Cited by 116
Brandmaier, A., Hou, S., & Shen, W. H. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.06.004 · Cited by 120
Huang, X. L., Khan, M. I., Wang, J., Ali, R., Ali, S. W., Zahra, Q. U. A., Kazmi, A., Lolai, A., Huang, Y., Hussain, A., et al. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.03.075 · Cited by 111
Targeting the Akt Kinase to Modulate Survival, Invasiveness and Drug Resistance of Cancer Cells
Cassinelli, G., Zuco, V., Gatti, L., Lanzi, C., Zaffaroni, N., Colombo, D., & Perego, P. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990106 · Cited by 108
Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases
Rodgers, S. J., Ferguson, D. T., Mitchell, C. A., & Ooms, L. M. (2017) · Bioscience Reports · doi:10.1042/bsr20160432 · Cited by 114
ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation
Alsina‐Sanchís, E., García-Ibáñez, Y., Figueiredo, A. M., Riera‐Domingo, C., Figueras, A., Matías‐Guiu, X., Casanovas, O., Botella, L. M., Pujana, M. Á., Riera-Mestre, A., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.310760 · Cited by 112
Schulz, J., Hartz, A. M. S., & Bauer, B. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000025 · Cited by 122
Li, H., Wen, X., Ren, Y., Fan, Z., Zhang, J., He, G., & Fu, L. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02072-1 · Cited by 125
The associations between Parkinson’s disease and cancer: the plot thickens
Feng, D. D., Cai, W., & Chen, X. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0043-z · Cited by 103
Kim, S.-J., Lee, H., Baek, J.-H., Yh, C., Kang, H. G., Jeong, J. S., Song, J., Park, H.-S., & Chun, K.-H. (2015) · Oncogene · doi:10.1038/onc.2015.80 · Cited by 102
PI3K/AKT pathway activation in bladder carcinogenesis
Caldéraro, J., Rebouissou, S., de Koning, L., Masmoudi, A., Hérault, A., Dubois, T., Maillé, P., Soyeux, P., Sibony, M., TAILLE, A. D. L., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28518 · Cited by 112
PTEN regulates RPA1 and protects DNA replication forks
Wang, G., Li, Y., Wang, P., Liang, H., Cui, M., Zhu, M., Guo, L., Su, Q. P., Sun, Y., McNutt, M. A., et al. (2015) · Cell Research · doi:10.1038/cr.2015.115 · Cited by 107
Inherited PTEN mutations and the prediction of phenotype
Leslie, N. R., & Longy, M. (2016) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2016.01.030 · Cited by 99
Emerging Role of miRNAs in the Drug Resistance of Gastric Cancer
Riquelme, I., Letelier, P. J., Riffo‐Campos, Á. L., Brebi, P., & Roa, J. C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030424 · Cited by 107
A Plasma Biomarker Panel of Four MicroRNAs for the Diagnosis of Prostate Cancer
Matin, F., Jeet, V., Moya, L., Selth, L. A., Chambers, S. K., BioResource, A. P. C., Yeadon, T. M., Saunders, P. T. K., Eckert, A., Heathcote, P. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24424-w · Cited by 114
Sahm, F., Bissel, J., Koelsche, C., Schweizer, L., Capper, D., Reuß, D., Böhmer, K., Laß, U., Göck, T., Kalis, K., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1187-5 · Cited by 101
Vaquero, J., Ho-Bouldoires, T. H. N., Clapéron, A., & Fouassier, L. (2017) · Oncogene · doi:10.1038/onc.2016.462 · Cited by 113
FBXO22 degrades nuclear PTEN to promote tumorigenesis
Ge, M.-K., Zhang, N., Li, X., Zhang, C., Dong, S.-S., Li, Z., Ji, Y., Zheng, M., Sun, J. P., Chen, G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15578-1 · Cited by 110
Wang, Y., Hersheson, J., Lopez, D., Hammer, M. B., Liu, Y., Lee, K.-H., Pinto, V., Seinfeld, J., Wiethoff, S., Sun, J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.044 · Cited by 112
Wang, G., Jiang, X., Pu, H., Zhang, W., An, C., Hu, X., Liou, A. K. F., Leak, R. K., Gao, Y., & Chen, J. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0157-2 · Cited by 108
The functions of tumor suppressor PTEN in innate and adaptive immunity
Chen, L., & Guo, D. (2017) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.30 · Cited by 111
Ramírez-Moya, J., Wert-Lamas, L., & Santisteban, P. (2018) · Oncogene · doi:10.1038/s41388-017-0088-9 · Cited by 113
Francis, J. C., Thomsen, M. K., Taketo, M. M., & Swain, A. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003180 · Cited by 100
Zmajkovicova, K., Jesenberger, V., Catalanotti, F., Baumgartner, C., Reyes, G., & Baccarini, M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.037 · Cited by 98
The non-coding transcriptome as a dynamic regulator of cancer metastasis
Crea, F., Clermont, P., Parolia, A., Wang, Y. Z., & Helgason, C. D. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9455-3 · Cited by 106
Bolduc, D., Rahdar, M., Tu-Sekine, B., Sivakumaren, S. C., Raben, D., Amzel, L. M., Devreotes, P., Gabelli, S. B., & Cole, P. (2013) · eLife · doi:10.7554/elife.00691 · Cited by 97
Targeted Therapies for Brain Metastases from Breast Cancer
Venur, V. A., & Leone, J. P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091543 · Cited by 96
Mitochondria-Associated Membranes As Networking Platforms and Regulators of Cancer Cell Fate
Sassano, M. L., van Vliet, A. R., & Agostinis, P. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00174 · Cited by 107
McCarroll, J. A., Gan, P. P., Erlich, R. B., Liu, M., Dwarte, T. M., Sagnella, S. S., Åkerfeldt, M. C., Yang, L., Parker, A. L., Chang, M. H. Y., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-2740 · Cited by 110
da Costa, R. M., Neves, K. B., Mestriner, F., Louzada‐Júnior, P., Bruder-Nascimento, T. B., & Tostes, R. C. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0443-0 · Cited by 101
“These results suggest an important crosstalk between inflammatory mediators and PTEN activity and are in line with the idea that PTEN is involved in apoptosis and inflammatory processes [18].”
BackgroundHuynh, D. L., Sharma, N., Singh, A. K., Sodhi, S. S., Zhang, J., Mongre, R. K., Ghosh, M., Kim, N., Park, Y. H., & Jeong, D. K. (2017) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(17)30005-5 · Cited by 111
PTEN loss in biopsy tissue predicts poor clinical outcomes in prostate cancer
Mithal, P., Allott, E. H., Gerber, L., Reid, J., Welbourn, W., Tikishvili, E., Park, J., Younus, A., Sangale, Z., Lanchbury, J. S. S., et al. (2014) · International Journal of Urology · doi:10.1111/iju.12571 · Cited by 98
Zhou, S., Wu, J., Shi, L., Li, X., Zhu, L., Sun, X., Qian, J., Wang, Y., Wei, J., & Ding, Q. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0620-3 · Cited by 101
Zhang, X.-F., Ye, Y., & Zhao, S. (2017) · Oncotarget · doi:10.18632/oncotarget.23336 · Cited by 105
Hou, Q., Rooman, M. J., & Pucci, F. (2023) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.3c00036 · Cited by 99
Dysregulation of AKT Pathway by SMYD2-Mediated Lysine Methylation on PTEN
Nakakido, M., Deng, Z., Suzuki, T., Dohmae, N., Nakamura, Y., & Hamamoto, R. (2015) · Neoplasia · doi:10.1016/j.neo.2015.03.002 · Cited by 100
Mechanical Ventilation Triggers Hippocampal Apoptosis by Vagal and Dopaminergic Pathways
González-López, A., López-Alonso, I., Aguirre, A., Amado‐Rodríguez, L., Batalla-Solís, E., Astudillo, A., Tomás‐Zapico, C., Fueyo, A., dos Santos, C. C., Talbot, K., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201304-0691oc · Cited by 105
PTEN Functions by Recruitment to Cytoplasmic Vesicles
Naguib, A., Bencze, G., Cho, H., Zheng, W., Tocilj, A., Elkayam, E., Faehnle, C. R., Jaber, N., Pratt, C. P., Chen, M., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.03.011 · Cited by 97
Sheean, M. E., McShane, E., Chéret, C., Walcher, J., Müller, T. H., Wulf-Goldenberg, A., Hoelper, S., Garratt, A. N., Krüger, M., Rajewsky, K., et al. (2014) · Genes & Development · doi:10.1101/gad.230045.113 · Cited by 110
Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target?
Braglia, L., Zavatti, M., Vinceti, M., Martelli, A. M., & Marmiroli, S. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118731 · Cited by 108
The role of PI3Kγ in the immune system: new insights and translational implications
Lanahan, S. M., Wymann, M. P., & Lucas, C. L. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00701-8 · Cited by 110
Meeusen, B., & Janssens, V. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.002 · Cited by 96
PTEN loss correlates with T cell exclusion across human cancers
Lin, Z., Huang, L., Li, S. L., Gu, J., Cui, X., & Zhou, Y. (2021) · BMC Cancer · doi:10.1186/s12885-021-08114-x · Cited by 106
Ohtake, Y., Park, D., Muneer, P. M. A., Li, H., Xu, B., Sharma, K., Smith, G. M., Selzer, M. E., & Li, S. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.02.037 · Cited by 104
Plk1 Phosphorylation of PTEN Causes a Tumor-Promoting Metabolic State
Li, Z., Li, J., Bi, P., Lu, Y., Burcham, G., Elzey, B. D., Ratliff, T., Konieczny, S. F., Ahmad, N., Kuang, S., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00814-14 · Cited by 96
Yue, S., Rao, J., Zhu, J., Busuttil, R. W., Kupiec-Weglinski, J. W., Lu, L., Wang, X., & Zhai, Y. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400280 · Cited by 95
Al‐Ali, H., Ding, Y., Slepak, T. I., Wu, W., Sun, Y., Martinez‐Ondaro, Y., Xu, X., Lemmon, V., & Bixby, J. L. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0931-17.2017 · Cited by 97
Polyphenols as Promising Drugs against Main Breast Cancer Signatures
Losada-Echeberría, M., Herranz‐López, M., Micol, V., & Barrajón‐Catalán, E. (2017) · Antioxidants · doi:10.3390/antiox6040088 · Cited by 102
TGF-β/PI3K/AKT/mTOR/NF-kB pathway. Clinicopathological features in prostate cancer
Torrealba, N., Vera, R., Fraile, B., Martínez-Onsurbe, P., Paniagua, R., & Royuela, M. (2019) · The Aging Male · doi:10.1080/13685538.2019.1597840 · Cited by 99
Zeb1 induces immune checkpoints to form an immunosuppressive envelope around invading cancer cells
Guo, Y., Lu, X., Chen, Y., Rendon, B. E., Mitchell, R. A., Cuatrecasas, M., Cortés, M., Postigo, A. A., Liu, Y., & Dean, D. C. (2021) · Science Advances · doi:10.1126/sciadv.abd7455 · Cited by 99
“Pten is not mutated in lung or pancreatic cancers where K-Ras is mutated, suggesting that this mutation is substituting for repression of Pten that occurs in these tumors ( 31 – 33 ). p53 mutation did not promote tumor initiation, but it did drive a metastatic phenotype ( 34 , 35 ).”
Impeded Nedd4-1-Mediated Ras Degradation Underlies Ras-Driven Tumorigenesis
Zeng, T., Wang, Q., Fu, J., Lin, Q., Bi, J., Ding, W., Qiao, Y., Zhang, S., Zhao, W., Lin, H., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.045 · Cited by 94
The tumor suppressor PTEN interacts with p53 in hereditary cancer
NAKANISHI, A., Kitagishi, Y., Ogura, Y., & Matsuda, S. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2377 · Cited by 107
Hsia, H., Kumar, R., Lucà, R., Takeda, M., Courchet, J., Nakashima, J. K., Wu, S., Goebbels, S., An, W., Eickholt, B. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400737111 · Cited by 107
Xu, L., Leng, H., Shi, X., Ji, J., Fu, J., & Leng, H. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.03.105 · Cited by 95
Lin, R., Zhan, M., Yang, L., Wang, H., Shen, H., Huang, S., Huang, X., Xu, S., Zhang, Z., Li, W., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1349-6 · Cited by 93
Tan, H., Zhang, S., Zhang, J., Zhu, L., Chen, Y., Yang, H., Chen, Y., An, Y., & Liu, B. (2020) · Theranostics · doi:10.7150/thno.47548 · Cited by 106
Regulatory role of microRNAs on PTEN signaling
Ghafouri‐Fard, S., Abak, A., Shoorei, H., Mohaqiq, M., Majidpoor, J., Sayad, A., & Taheri, M. N. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110986 · Cited by 97
Jiang, T., Shi, Y., Cui, X.-W., Pan, Y., Lin, Y., Feng, X., Ding, Z., Yang, C., Tan, Y., Dong, L., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.11.025 · Cited by 93
Long-term p110α PI3K inactivation exerts a beneficial effect on metabolism
Foukas, L. C., Bilanges, B., Bettedi, L., Pearce, W., Ali, K., Sancho, S., Withers, D. J., & Vanhaesebroeck, B. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201953 · Cited by 91
Yu, T., Cao, R., Li, S., Fu, M., Ren, L., Chen, W., Zhu, H. Y., Zhan, Q., & Shi, R. (2015) · BMC Cancer · doi:10.1186/s12885-015-1031-5 · Cited by 98
Vulnerabilities of PTEN – TP53 -Deficient Prostate Cancers to Compound PARP–PI3K Inhibition
González-Billalabeitia, E., Seitzer, N., Song, S. J., Song, M. S., Patnaik, A., Liu, X.-S., Epping, M. T., Papa, A., Hobbs, R. M., Chen, M., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0230 · Cited by 92
Self-citationPI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas
Nozhat, Z., & Hedayati, M. (2015) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-015-0175-y · Cited by 95
Therapeutic targeting of CK2 in acute and chronic leukemias
Buontempo, F., McCubrey, J. A., Orsini, E., Ruzzene, M., Cappellini, A., Lonetti, A., Evangelisti, C., Chiarini, F., Evangelisti, C., Barata, J. T., et al. (2017) · Leukemia · doi:10.1038/leu.2017.301 · Cited by 95
miRNAs as Influencers of Cell–Cell Communication in Tumor Microenvironment
Conti, I., Varano, G., Simioni, C., Laface, I., Milani, D., Rimondi, E., & Neri, L. M. (2020) · Cells · doi:10.3390/cells9010220 · Cited by 100
Malic Enzyme 1 as a Novel Anti‐Ferroptotic Regulator in Hepatic Ischemia/Reperfusion Injury
Fang, X., Zhang, J., Li, Y., Song, Y., Yu, Y., Cai, Z., Lian, F., Yang, J., Min, J., & Wang, F. (2023) · Advanced Science · doi:10.1002/advs.202205436 · Cited by 100
Targeting PI 3‐kinase ( PI 3 K ), AKT and m TOR axis in lymphoma
Blachly, J. S., & Baiocchi, R. A. (2014) · British Journal of Haematology · doi:10.1111/bjh.13065 · Cited by 101
Labak, C. M., Wang, P. Y., Arora, R., Guda, M. R., Asuthkar, S., Tsung, A. J., & Velpula, K. K. (2016) · Europe PMC (PubMed Central) · Cited by 111
Modulation, Plasticity and Pathophysiology of the Parallel Fiber-Purkinje Cell Synapse
Hoxha, E., Tempia, F., Lippiello, P., & Miniaci, M. C. (2016) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2016.00035 · Cited by 112
Aquila, S., Santoro, M., Caputo, A., Panno, M. L., Pezzi, V., & Amicis, F. D. (2020) · Cells · doi:10.3390/cells9071725 · Cited by 103
PTEN C-Terminal Deletion Causes Genomic Instability and Tumor Development
Sun, Z., Huang, C., He, J., Lamb, K. L., Kang, X., Gu, T., Shen, W. H., & Yin, Y. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.01.030 · Cited by 88
Targeting ribonucleotide reductase for cancer therapy
Shao, J., Liu, X., Zhu, L., & Yen, Y. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.840293 · Cited by 92
Phosphotyrosine recognition domains: the typical, the atypical and the versatile
Kaneko, T., Joshi, R., Feller, S. M., & Li, S. S. ‐. (2012) · Cell Communication and Signaling · doi:10.1186/1478-811x-10-32 · Cited by 104
Metadata
- Authors
- Song, M. S., Salmena, L., & Pandolfi, P. P.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Song, Min Sup
- Salmena, Leonardo
- Pandolfi, Pier Paolo
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2012-04-04
- Volume
- 13
- Issue
- 5
- Pages
- 283-296
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2017739035
- Cited by
- 1,926
- References
- 159
- Citations by year
- 2026: 50 · 2025: 81 · 2024: 85 · 2023: 100 · 2022: 124 · 2021: 113 · 2020: 147 · 2019: 155 · 2018: 172 · 2017: 183 · 2016: 167 · 2015: 182 · 2014: 199 · 2013: 136 · 2012: 31
- FWCI
- 15.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Canadian Institutes of Health Research
- National Cancer Institute (R01 CA-82328-09, R01CA082328)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- PTEN, phosphatase and tensin homologue, tumour suppressor, PI3K/AKT/mTOR pathway, lipid phosphatase activity, transcriptional regulation, non-coding RNA, post-translational modification, protein-protein interaction, cancer therapy, energy metabolism, cell proliferation
- MeSH terms
- Animals, Cell Nucleus, Gene Expression Regulation, Humans, Mutation, Neoplasms, Protein Conformation, Neoplastic Stem Cells, Signal Transduction, Tumor Suppressor Proteins, PTEN Phosphohydrolase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.